
Our lab, in conjunction with the Transformative Center for Nanomedicine, has openings for postdocs and research technicians. Email eunchung@usc.edu with CV and interests, and for more information.

Prof @uscbme | Educator | Innovator | Director Transformative Nanomedicine | Director SPARK USC | Founder SSTX | Author amazon.com/dp/B09YMTWC5L

Our lab, in conjunction with the Transformative Center for Nanomedicine, has openings for postdocs and research technicians. Email eunchung@usc.edu with CV and interests, and for more information.

Having an extended solo trip in Toronto so making the most of it. Hangeul - the Korean language: this caption captures so well how innovative and ahead of his time King Sejong was circa 1443. @ROMtoronto Also enjoying the Xmas festivities which have already begun here 🎄🍁🇨🇦

Thank you to IMS and student organizers Joanna and Slaghaniya for inviting me as keynote speaker for the Ori Rotstein Lectureship. I had the *best time* interacting with all the faculty and students, and it was an honor meeting Dr. Ori Rotstein himself. Til next time! 💌
What a fantastic morning at the 16th Annual Ori Rotstein Lecture in Translational Research! We were honoured to host Dr. Eunji Chung and an outstanding panel of researchers who shared insights, experiences, and inspiration with our IMS community. Thank you to everyone who contributed behind the scenes and to all who joined us in-person and online. 📸 A few of the people who helped make it happen.

Awesome visit to @ChildrensLA. Thank you to Juli Wu for hosting. Wonderful to connect with current collaborators and forge new collaborative strategies for rare/childhood diseases. Always hits differently visiting hospitals dedicated to kids. Will bring it back to the lab. 💪

THIS IS INSANE: USC TE MARK BOWMAN JUST MADE ONE OF THE CRAZIEST PLAYS OF THE COLLEGE FOOTBALL SEASON AGAINST OHIO STATE. BOWMAN HURDLED ONE DEFENDER, LANDED ON HIS FEET, AND THEN TRUCKED ANOTHER DEFENDER TO KEEP GOING. 😳😳😳

Halloween festivities - always a good idea to inject some whimsy and creativity into the day. @TheChungLab Bugs Life 🐜 🐛

Start of a new collaboration with @USCWrigley! So lucky to be a part. And with the freshest oysters possible! 🦪

Day 0 and 1 of @ASNKidney #KidneyWk! Always keep it moving so nanotherapeutics can make the impact for the clinic. Looking forward to Day 2 and 3! @kidneyrebel @kapitsinou @GiblinJoshua @PKDFoundation

Our lab is accepting Postdoc and research technician applicants - those that are committed to collaborative research and supporting therapeutic development are encouraged to apply!
Our lab, in conjunction with the Transformative Center for Nanomedicine, has openings for postdocs and research technicians. Email eunchung@usc.edu with CV and interests, and for more information.

“We are all living in cages with the door wide open.” — George Lucas

Apply now for Round 4 of the OKRA Opportunity Pool Program! Submissions close next Tues., Oct. 20, at 5pm CT. Full application details, including eligibility requirements, application components, & contact info can be found in the NOFO on the OKRA website:uab.edu/okra/funding/okra-op…

We had a meaningful and productive day via the 3rd symposium hosted by the USC Transformative Center for Nanomedicine and DD. We all got to work across the sectors, learning from e/o toward our shared goal in developing therapeutics for patients. 💪 #teamworkmakesthedreamwork

BREAKING NEWS The 2026 #NobelPrize in Physiology or Medicine has been awarded to Karl Deisseroth, Peter Hegemann and Georg Nagel “for their discoveries concerning light-gated ion channels and optogenetics.”

Read a ton of books over the last few months but this one is particularly illuminating. Learning more about my workplace from the last few decades:

It’s just so cool and personally encouraging to see this sign right in front of my building. 🫰

🧬 Excited to share our new work in @NatureBiotech! Paper: nature.com/articles/s41587-0… Research Briefing: nature.com/articles/s41587-0… Large gene editors require large mRNAs, but LNPs are typically discovered using much smaller reporter RNAs. We asked: does RNA size matter when discovering delivery lipids? Using a large base-editor mRNA for high-throughput screening, we identified LC-1, an ionizable lipid that enabled efficient gene editing in the liver, lung, and brain via different administration routes in mice, with up to 4× higher Cas9 editing than benchmark LNPs. LC-1 also efficiently delivered base editors for disease-relevant targets in hypercholesterolemia, cystic fibrosis, and Angelman syndrome. Why does LC-1 work so well? Cryo-EM and X-ray scattering revealed that LC-1 LNPs form an ordered, inverted-hexagonal structure that persists with large RNA cargo. This membrane-fusing structure helps RNA escape from endosomes, the compartments that can trap it inside cells. In cell studies, LC-1 released roughly twice as much large mRNA into the cytosol as the benchmark formulations. We show that LC-1's key design features also apply to ionizable lipids made through other synthetic routes. These findings show that accounting for RNA size from the start can change which lipids we discover and improve delivery of large gene editors. This could help expand the delivery options available for future gene-editing medicines. Thank you to all our co-authors, collaborators and funders @CIHR_IRSC @NSERC_CRSNG @UofTPharmacy @LisaDolovich @PMResearch_UHN @bradwouters #LipidNanoparticles #GeneEditing #RNATherapeutics